News + Blog
Find out what’s happening on campus and across the industry.
Read Fitzsimons Innovation Community news, industry highlights, editorials, and innovation updates happening weekly on our campus.
Sort By:
-
- News
HepQuant Named Rising Star of the Year Finalist by Colorado BioScience Association
HepQuant, a member of Fitzsimons Innovation Community, has been named a Rising Star of the Year finalist for the Colorado BioScience Association’s 23rd Annual Awards Celebration, recognizing emerging life sciences companies advancing innovation and improving patient care. HepQuant joins fellow finalists Think Bioscience and VitriVax in the category, with winners to be announced at the… -
- Newsletter
Newsletter – November 2026
The November 2026 edition of Breakthrough News and Views highlights emerging innovations, company achievements and continued growth at Fitzsimons Innovation Community. President and CEO Kelly Brough reflects on the importance of supporting early-stage ideas and creating an environment where companies can explore new approaches, navigate challenges and advance scientific discoveries. The Innovation Spotlight celebrates Intero Biosystems’ victory at… -
- News
3i Chooses Fitzsimons Innovation Community for New Headquarters
Colorado-born microscopy company will bring manufacturing, research and customer demonstration capabilities closer to one of Colorado’s largest concentrations of biomedical researchers AURORA, Colo. – October 21, 2026 – Intelligent Imaging Innovations (3i), a Colorado-based developer and manufacturer of advanced microscopy systems, is relocating its headquarters to Bioscience 3 at Fitzsimons Innovation Community. The move is… -
- News
Intero Biosystems Wins Startup Battlefield at TechCrunch Disrupt 2026
Intero Biosystems, a member of Fitzsimons Innovation Community, has been named the winner of Startup Battlefield at TechCrunch Disrupt 2026, earning national recognition for its innovative approach to biotechnology. The achievement highlights Intero’s growing presence in the life sciences industry and brings additional visibility to the innovative companies advancing scientific discovery and commercialization within Colorado’s… -
- Newsletter
Newsletter – October 2026
The October 2026 newsletter explores the value of proximity in accelerating scientific discovery, strengthening professional relationships and supporting the growth of life sciences companies. President and CEO Kelly Brough reflects on how access to researchers, clinicians, entrepreneurs and specialized resources contributes to the collaborative environment at Fitzsimons Innovation Community. The Innovation Spotlight features the Gates… -
- News
Fitzsimons Innovation Community Welcomes Georgia Leadership Delegation
Fitzsimons Innovation Community recently welcomed 47 business, civic and community leaders from Georgia as part of the Greater North Fulton Chamber of Commerce’s 2026 Strategic Leadership Visit to the Denver metropolitan area. The three-day visit provided opportunities for regional leaders to explore approaches to economic development, transportation, redevelopment and innovation. During their visit to Fitzsimons,… -
- News
Pathways Bioscience’s PB125 Shows Promising Results in Human Vascular Health Study
Pathways Bioscience, a member of Fitzsimons Innovation Community, has announced the publication of new clinical research demonstrating that its proprietary botanical formulation, PB125, improved vascular function in older adults and helped preserve vascular function during periods of physical inactivity. The randomized, double-blind, placebo-controlled study, independently conducted by researchers affiliated with the University of Utah, Salt… -
- News
Children’s Hospital Colorado Recognizes Emerging Pediatric Researchers
The Colorado Child Health Research Institute at Children’s Hospital Colorado has announced its spring 2026 research award recipients, recognizing early-career investigators advancing innovative approaches to pediatric health challenges. Supported in part by philanthropic investment, the awards provide funding for research addressing conditions including traumatic brain injury, chronic lung disease and other complex pediatric health concerns…. -
- News
CU Anschutz Receives FDA Clearance for CAR T-Cell Cancer Therapy Trial
The University of Colorado Anschutz has received clearance from the U.S. Food and Drug Administration (FDA) to begin a clinical trial investigating an experimental CAR T-cell therapy for adults with advanced colorectal cancer and pediatric patients with certain solid tumors. Developed by CU Anschutz researchers, the treatment uses genetically modified immune cells designed to target… -
- Newsletter
Newsletter – September 2026
The September 2026 newsletter explores the advantages of building and growing a life sciences company in Aurora, Colorado. President and CEO Kelly Brough highlights the city’s expanding healthcare and research ecosystem, diverse community, quality of life and strong public-sector partnerships that support innovation at Fitzsimons. The Innovation Spotlight recognizes Cobio Diagnostics for securing a $2.2… -
- News
Fitzsimons Innovation Community Partners With Aurora Public Schools on Student Mural Project
Fitzsimons Innovation Community is partnering with Aurora Public Schools and NINE dot ARTS to bring a collaborative public art project to its campus during the 2026-27 school year. The initiative will engage 12th-grade students from the Charles Burrell Visual & Performing Arts Campus in creating a mural that reflects Fitzsimons’ mission, values and connection to… -
- News
Cobio Diagnostics Secures $2.2 Million NIH Grant to Advance Rapid Infection Testing
Cobio Diagnostics, a member of Fitzsimons Innovation Community, has received a $2.2 million Small Business Innovation Research (SBIR) Fast-Track grant from the National Institutes of Health (NIH) to advance its rapid diagnostic technology for urinary tract infections. The funding will support development of a diagnostic test designed to identify infection-causing bacteria directly from patient samples…